MRK is my suspect, I’ve been doing a pattern of life on them….
Merck’s Cash Power:
With $15.5B in Q1 2025 revenue and a robust balance sheet, Merck can afford to take risks on speculative assets.
I’m watching them.
(10)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-